BWI: Ocimum Biosolutions B.V. Introduces Affymetrix Services in Europe

Press release from Business Wire India
Source: Ocimum Biosolutions
Tuesday, May 05, 2009 01:26 PM IST (07:56 AM GMT)
Editors: General: Consumer interest; Business: Advertising, PR & marketing, Business services, Healthcare, biotechnology & pharmaceutical; Technology; Healthcare
Release no: 19865
--------------------------------------------------
Ocimum Biosolutions B.V. Introduces Affymetrix Services in Europe
Launches Expanded Range of Genomics Services from its Netherlands Facility

IJsselstein, Netherlands, Tuesday, May 05, 2009 -- (Business Wire India) -- In line with its strategic objective to build a global network of service centers in close proximity to leading genomics researchers, Ocimum Biosolutions B.V. today announced the launch of genomic services on Affymetrix platform from Europe. Initially Ocimum will service Gene Expression studies on the Affymetrix platform from its facility at IJsselstein, The Netherlands. Within a couple of months, it will launch the entire bouquet of services from its IJsselstein facility.

"Ocimum-Gene Logic is focused on providing high quality, validated and industry leading services to our clients worldwide. With the introduction of Affymetrix based genomics services in Europe, we are now available at the doorsteps of leading lifescience companies and research centers in Europe. Having replicated the same protocols which are used in our GLP compliant Gaithersburg facility, our European center would also now generate and analyze genomic and gene expression data with the same quality and attention to detail that make us the partner of choice for two-thirds of the top 25 pharmaceutical/biotech companies and research centers." says Anu Acharya, CEO, Ocimum Biosolutions and Gene Logic.

"We share a long-standing and deep relationship with Ocimum-Gene Logic," said Kevin King, President and CEO of Affymetrix. "Gene Logic has been an Authorized Service Provider for Affymetrix for more than a decade, providing genomic services on the Affymetrix platform from its Gaithersburg lab, which is one of the largest commercial microarray facilities in the world. We are very proud to be associated with this exciting expansion."


For more information, please visit www.genelogic.com/services or e-mail to europe@ocimumbio.com.


About Ocimum Biosolutions

Ocimum Biosolutions is a leading integrated genomics company providing comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers.

We are a preferred outsourcing partner for providing integrated biorepository and genomic services for several global pharmaceutical companies. Our global infrastructure, standardized procedures, capacity, expertise and highly skilled staff support drug development programs from pre-clinical target development and toxicogenomic assessment to clinical biomarker identification and patient stratification. In creating the world's largest commercial gene expression databases - BioExpress® and ToxExpress®, we have developed expertise and capabilities that are unparalleled in the genomic services industry. We provide multiple GLP-compliant platforms for gene expression and SNP genotyping data generation. We also provide full biorepository and genomic services support for the Genetic Alliance, which is an umbrella organization representing ~600 genetic advocacy groups. Besides providing the physical infrastructure for storing thousands of biological samples, we provide services to assist sample accrual, IRB approvals, CRO training, sample collection, clinical data capture and management.

About Affymetrix

Affymetrix GeneChip® microarray technology is the industry-standard tool for analyzing complex genetic information. After inventing microarray technology in the late 1980s, Affymetrix scientists have been dedicated to developing innovative products that provide researchers with a more complete view of the genome. These products continue to accelerate genetic research. They enable scientists to develop diagnostics which may support the tailoring of treatments for patients by identifying and measuring the genetic information associated with complex diseases.

Today, Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and not-for-profit research institutes. More than 1,800 systems have been shipped around the world and more than 16,000 peer-reviewed papers have been published using the technology.

Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Cleveland, Ohio, and Singapore. The company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe and Asia. For more information about Affymetrix, please visit the company's website at www.affymetrix.com.




CONTACT DETAILS
Ms. Dhanya Menon, Ocimum Biosolutions, +91 (40) 66627200, pr@ocimumbio.com

KEYWORDS
CONSUMER, MARKETING, BUSINESS SERVICES, HEALTHCARE, TECHNOLOGY, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com